Sea Pharmaceuticals Financing
Sea Pharmaceuticals, Llc, Limited Liability Company just had published form D regarding $3.50 million equity financing. The date of first sale was 2016-02-19. Sea Pharmaceuticals was able to fundraise $887,000 so far. That is 25.34% of the fundraising. The total financing amount was $3.50 million. The financing document was filed on 2016-11-15. The reason for the financing was: unspecified. The fundraising still has about $2.61 million more and is not closed yet. We have to wait more to see if the offering will be fully taken.
Sea Pharmaceuticals is based in Massachusetts. The company’s business is Pharmaceuticals. The form was submitted by James P Pearson President. The company was incorporated in 2013. The filler’s address is: 14 Gray Street, Cambridge, Ma, Massachusetts, 02138. James P. Pearson is the related person in the form and it has address: 14 Gray Street, Cambridge, Ma, Massachusetts, 02138. Link to Sea Pharmaceuticals Filing: 000166767716000002.
Analysis of Sea Pharmaceuticals Offering
On average, companies in the Pharmaceuticals sector, sell 60.90% of the total offering amount. Sea Pharmaceuticals sold 25.34% of the offering. The fundraising is still open. The average investment floor size for companies in the Pharmaceuticals industry is $556,000. The total amount raised is 59.53% bigger than the average for companies in the Pharmaceuticals sector. The minimum investment for this financing was set at $5000. If you know more about the reasons for the financing, please comment below.
What is Form D? What It Is Used For
Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.
Why Fundraising Reporting Is Good For Sea Pharmaceuticals Also
The Form D signed by James P Pearson might help Sea Pharmaceuticals, Llc’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.